-

CRO Activity and Intel Report, Q1 2025 - CRO and Sponsor Activity, Clinical Trial Trends, and Geographical Performance Across Various Therapeutic Areas - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Q1 2025 CRO Activity and Intel Report" report has been added to ResearchAndMarkets.com's offering.

This report provides an in-depth analysis of the contract research organization (CRO) industry for Q1 2025, segmented by geography, therapeutic area, and phase of development. It delivers insights into CRO and sponsor activity, clinical trial trends, and geographical performance across various therapeutic areas.

Reasons to Buy

  • This report will enable the user to answer the following questions:
  • What are the trends by region, therapy area, sites by CROs for the past quarter?
  • Who was the most active CRO in the past quarter?
  • Who were the most active sponsors by market cap in the past quarter?
  • What was the most widely studied therapy area in the past quarter vs. the previous year's quarter?
  • By region, who had the most clinical trials initiated in the past quarter?
  • By region, what were the past quarter's CRO invitations and appointments?

Key Topics Covered:

Global

  • CRO and sponsor activity in Q1 2025
  • Most-used CROs
  • Most active large- and mega-cap sponsors
  • Most active mid-cap sponsors
  • Most active small-cap sponsors
  • Clinical trials in oncology and CNS
  • Therapeutic area breakdown of clinical trials initiated in Q1 2025 vs. Q1 2024
  • Trials initiated in the 10 most active oncology indications in Q1 2025 vs. Q1 2024
  • Trials initiated in the 10 most active CNS indications in Q1 2025 vs. Q1 2024
  • Top 10 CROs by number of sites in Q1 2025

North America

  • Clinical trial activity in North America in Q1 2025
  • Most active North American regions in Q1 2025 vs. Q1 2024
  • Phase breakdown of trials initiated in North America in Q1 2025 vs. Q1 2024
  • Therapeutic area breakdown of clinical trials initiated in North America in Q1 2025 vs. Q1 2024
  • Top 10 trial sites by trials initiated in North America in Q1 2025
  • Insights: CRO invites for sponsors based in North America
  • Insights: CRO appointments for sponsors based in North America

Europe

  • Clinical trial activity in Europe in Q1 2025
  • Most active European regions in Q1 2025 vs. Q1 2024
  • Phase breakdown of trials initiated in Europe in Q1 2025 vs. Q1 2024
  • Therapeutic area breakdown of clinical trials initiated in Europe in Q1 2025 vs. Q1 2024
  • Top 10 trial sites by trials initiated in Europe in Q1 2025
  • Insights: CRO invites for sponsors based in Europe
  • Insights: CRO appointments for sponsors based in Europe

Rest of the world

  • Clinical trial activity in ROW in Q1 2025
  • Most active regions in ROW in Q1 2025 vs. Q1 2024
  • Phase breakdown of trials initiated in ROW in Q1 2025 vs. Q1 2024
  • Therapeutic area breakdown of clinical trials initiated in ROW in Q1 2025 vs. Q1 2024
  • Top 10 trial sites by trials initiated in ROW in Q1 2025

A selection of companies mentioned in this report includes, but is not limited to:

  • ICON
  • Astrazeneca
  • Akesobio
  • CSPPC Pharmaceutical
  • ImmunityBio
  • Boryung

For more information about this report visit https://www.researchandmarkets.com/r/j9ak83

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Poland Investment Funds and Asset Management Market Report 2026, Profiles of TFI, Pekao, Santander, PKO, Allianz, Goldman Sachs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investment Funds and Asset Management Market in Poland, 2024-2026" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive overview of the investment funds and asset management sector in Poland. Analysis covers the main pillars of the market, including: mutual funds, insurance, and pension assets. The report also mid-term forecast of key volumes for the period 2025-2027. The data has been presented in a form of horizontal pr...

Europe Data Center Colocation Market Outlook & Forecast Report 2025-2030 Featuring Major Players - Digital Realty, Equinix, NTT DATA, Global Switch, CyrusOne, Ark Data Centres - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Data Center Colocation Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Europe Data Center Colocation Market was valued at USD 9.45 Billion in 2024, and is projected to reach USD 35.73 Billion by 2030, rising at a CAGR of 24.82%. The Europe data center colocation market is expected to witness cumulative investments of approximately $144.03 billion, of which, the Western Europe is slated to ac...

GCC Construction Equipment Market Research Report 2025-2030 Featuring Key Vendors - Caterpillar, Komatsu, Volvo, Hitachi, SANY, XCMG, JCB, Liebherr, Kobelco, and Zoomlion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GCC Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering. The GCC Construction Equipment Market was sized at 68,499 Units in 2024, and is projected to reach 94,499 Units by 2030, rising at a CAGR of 5.51%. Governments in the UAE and Saudi Arabia continue to prioritize urban growth and diversification, with Dubai's long-term 2040 Urban Master Plan and the Saudi Vision 2030-linked mega-projects fuelling o...
Back to Newsroom